SEER vs. GANX
SEER (Seer, Inc.) and GANX (Gain Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, SEER returned -44.99%/yr vs -30.04%/yr for GANX. At a 0.21 correlation, their price movements are largely independent.
Performance
SEER vs. GANX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SEER achieves a -7.65% return, which is significantly higher than GANX's -45.96% return.
SEER
- 1D
- -2.31%
- 1M
- -5.59%
- YTD
- -7.65%
- 6M
- -8.15%
- 1Y
- -14.21%
- 3Y*
- -27.42%
- 5Y*
- -44.99%
- 10Y*
- —
GANX
- 1D
- -1.69%
- 1M
- -2.25%
- YTD
- -45.96%
- 6M
- -45.96%
- 1Y
- -2.79%
- 3Y*
- -27.15%
- 5Y*
- -30.04%
- 10Y*
- —
SEER vs. GANX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
SEER Seer, Inc. | -7.65% | -20.78% | 19.07% | -66.55% | -74.57% | -58.32% |
GANX Gain Therapeutics, Inc. | -45.96% | 49.07% | -33.84% | 4.31% | -42.36% | -51.60% |
Correlation
The correlation between SEER and GANX is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Mar 18, 2021 | 0.21 |
Fundamentals
SEER:
$94.63M
GANX:
$73.48M
SEER:
-$1.24
GANX:
-$0.60
SEER:
0.39
GANX:
5.25
SEER:
$15.17M
GANX:
$0.00
SEER:
$7.39M
GANX:
$2.13M
SEER:
-$63.20M
GANX:
-$19.59M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SEER vs. GANX — Risk / Return Rank
SEER
GANX
SEER vs. GANX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Seer, Inc. (SEER) and Gain Therapeutics, Inc. (GANX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SEER | GANX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.31 | ||
| Sortino ratioReturn per unit of downside risk | -1.04 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 1.11 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | -0.48 | -0.05 | -0.43 |
| Martin ratioReturn relative to average drawdown | -0.79 | -0.07 | -0.71 |
Loading charts...
Drawdowns
SEER vs. GANX - Drawdown Comparison
The maximum SEER drawdown since its inception was -98.25%, roughly equal to the maximum GANX drawdown of -94.08%. Use the drawdown chart below to compare losses from any high point for SEER and GANX.
Loading charts...
Drawdown Indicators
| SEER | GANX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.25% | -94.08% | -4.17% |
Max Drawdown (1Y)Largest decline over 1 year | -29.96% | -61.96% | +32.00% |
Max Drawdown (3Y)Largest decline over 3 years | -73.37% | -81.43% | +8.06% |
Max Drawdown (5Y)Largest decline over 5 years | -96.74% | -91.13% | -5.61% |
Current DrawdownCurrent decline from peak | -97.99% | -88.99% | -9.00% |
Average DrawdownAverage peak-to-trough decline | -86.24% | -75.53% | -10.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.06% | 37.72% | -19.66% |
Volatility
SEER vs. GANX - Volatility Comparison
The current volatility for Seer, Inc. (SEER) is 9.81%, while Gain Therapeutics, Inc. (GANX) has a volatility of 21.50%. This indicates that SEER experiences smaller price fluctuations and is considered to be less risky than GANX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SEER | GANX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.81% | 21.50% | -11.69% |
Volatility (6M)Calculated over the trailing 6-month period | 33.49% | 69.90% | -36.41% |
Volatility (1Y)Calculated over the trailing 1-year period | 42.38% | 110.23% | -67.85% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 73.71% | 86.14% | -12.43% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 77.24% | 85.14% | -7.90% |
Dividends
SEER vs. GANX - Dividend Comparison
Neither SEER nor GANX has paid dividends to shareholders.
Financials
SEER vs. GANX - Financials Comparison
This section allows you to compare key financial metrics between Seer, Inc. and Gain Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SEER and GANX have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GANX has higher volatility (21.50%) compared to SEER (9.81%). In terms of maximum drawdown, SEER dropped -98.25% vs GANX's -94.08%.
GANX currently has the higher Sharpe Ratio (-0.03 vs -0.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SEER and GANX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer